Evaluation of analgesic effect according to dose of BMI component: BMI component dose response test. by Geun Joo Choi (7391252)

Evaluation of analgesic effect according to dose of BMI1008: BMI1008 dose response test. by Geun Joo Choi (7391252)

Mean volume and mean apical surface of chick neuroepithelial cells decreases between 2 and 3 days of development. by Marina A. Ferreira (8174169)

Representative images of a subsolid nodule in Low-dose and Ultralow-dose CT scans with iterative and deep-learning reconstruction algorithms. by Seung-Jin Yoo (2983260)

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

Inhibitor versus the normalized dose response curves. by Bryan S. Margulies (21492667)

Dose-response curves for benzimidazoles (BZs). by Amanda O. Shaver (3263472)

Dose-response curve for monepantel sulfone. by Amanda O. Shaver (3263472)

Dose-response curve for monepantel sulfide. by Amanda O. Shaver (3263472)

Representation of the 210 significant associations between dose and cognitive and neuropsychological evaluations scores. by Claudia Cavatorta (10204548)

“…<p>The associations were obtained through the Kruskal-Wallis analysis and 83 ROIs and 17 different tests were involved. For each ROI reported on the x-axis, all scores showing a significant association with dose are reported on the y-axis in the form of colored boxes. …”

Means, standard deviations and intercorrelations. by Cheri Ostroff (13868468)

Comparative effectiveness and safety of low-dose and standard-dose rivaroxaban after inverse probability of treatment weighting. by Sylvie Perreault (3574211)

Subjects:

Comparative effectiveness and safety of low-dose and standard-dose apixaban after inverse probability of treatment weighting. by Sylvie Perreault (3574211)

Subjects:

Heat map and k-means clustering of proteins (384) for which any Vpu-mutant was significantly different from wild type. by Charlotte A. Stoneham (10819125)

Resveratrol dose response. by Neda Heidari (19469394)

Counts and percentages of members who had documentation of select conditions prior to initiation of SAC/VAL (Baseline) and while taking it (Follow-Up) as a function of different dose trajectories, as well as indicators of significance and effect sizes for differences across dose trajectory groups. by Jillian M. Rung (9253449)

Subjects:

PVS_ratio changes, ΔPVS_ratio, for different radiation doses within each treatment period: 0M–3M(a), 3M–12M(b), and 12M–FollowUp(c). by Ruitian Song (11045127)

The number of people infected depends on vaccine rates and structure but not number of doses. by Gregg Hartvigsen (191990)

Between group differences for the ‘NAC group’ and ‘no-NAC group’. by Davinder Hans (12015279)

Mating significantly increases survival and bacterial load in females infected with a high dose of <i>S. marcescens.</i> by Brendan J. Kelly (7329878)